Wanbury Limited (NSE: WANBURY)
India flag India · Delayed Price · Currency is INR
238.25
+10.15 (4.45%)
Jan 14, 2025, 3:29 PM IST

Wanbury Company Description

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally.

The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner.

It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas.

The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004.

Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Wanbury Limited
Wanbury logo
Country India
Founded 1988
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,491
CEO Mohan Rayana

Contact Details

Address:
BSEL Tech Park, B-Wing
Navi Mumbai, Maharashtra 400703
India
Phone 91 22 6794 2222
Website wanbury.com

Stock Details

Ticker Symbol WANBURY
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE107F01022
SIC Code 2834

Key Executives

Name Position
Pradeep Patni Chief Executive Officer of India Formulation Business
Mohan Kumar Rayana Whole Time Director
Krishnamoorthy Chandran Vice Chairman
Vinod R. Verma Chief Financial Officer
Jitendra Jayantilal Gandhi Compliance Officer and Company Secretary
Dr. Shireesh Bhalchandra Ambhaikar President of Operations - API Business
Nanasaheb Gunjal Senior Vice President of QA,QC and RA
Prakash Venkataraman B.E., MBA Head of API Business